NEURON23

Neuron23 was founded in late 2018 with the goal of changing the way drugs were discovered and developed for neurodegenerative and immunological diseases, by leveraging data science to pinpoint and exploit key disease drivers. Since then, a world class team of drug hunters, geneticists, chemists, biologists and entrepreneurs have joined hands and minds and built the infrastructure to achieve this mission... Our intention is simple, but our work is not. Combining cutting-edge data science and human genetics, we're creating precision medicines to fight debilitating diseases... We're a diverse team with proven success in both science and business, driven by one common goal: enhancing and improving the lives of the patients we serve. Compassion is at our core, and we're on a never-ending mission to create the type of breakthroughs that can propel the world forward.

Primary location: South San Francisco United States